首页> 外文期刊>Clinical microbiology and infection: European Society of Clinical Microbiology and Infectious Diseases >European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI).
【24h】

European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI).

机译:欧洲临床微生物学和传染病学会(ESCMID):艰难梭菌感染(CDI)的治疗指导文件。

获取原文
获取原文并翻译 | 示例
           

摘要

Clostridium difficile infection (CDI) is a potentially fatal illness with an increasing incidence worldwide. Despite extensive ongoing research into CDI treatment, management of CDI still poses important problems, such as a high propensity to relapse and refractoriness to treatment, especially when there is an ileus and oral drugs cannot be administered. This guideline evaluates the available literature, discusses criteria for disease severity and provides recommendations for CDI treatment, indicating level of evidence and strength of recommendation.
机译:艰难梭菌感染(CDI)是一种潜在的致命疾病,在世界范围内发病率不断上升。尽管对CDI治疗进行了广泛的研究,但CDI的管理仍然存在重要的问题,例如复发的可能性高和治疗的难治性,特别是在存在肠梗阻和不能口服药物的情况下。该指南评估了现有文献,讨论了疾病严重程度的标准并为CDI治疗提供了建议,指出了证据水平和建议强度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号